Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.

CONCLUSIONS: This novel application would detect early phase or incomplete pathological cases of AMR, which could lead to a correct diagnosis and initiation of appropriate therapies. Moreover, graft ICFA might address a variety of long-standing questions in terms of DSA. ABBREVIATIONS: AMR: Antibody-mediated rejection; DSA: Donor-specific antibodies; ICFA: Immunocomplex capture fluorescence analysis. PMID: 28151033 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28151033?dopt=Abstract

Source: Immunological Investigations - February 4, 2017 Category: Allergy & Immunology Tags: Immunol Invest Source Type: research

More News: Allergy & Immunology | Bone Graft